3 unknown. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
Follow Myelitis: new trials by email Literature Review of Myelitis trials Research Report on Myelitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age LR20062, DTaP-HepB-IPV-Hib vaccine - Diphtheria, Tetanus | Phase 2 | Unknown | LG Chem | 336 | 2024-10-02 | 2024-10-01 |
| Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants DTwP-HepB-Sabin IPV-Hib, Pentavalent vaccine and Salk IPV - Diphtheria, Tetanus | Phase 2 | Unknown | LG Chem | 336 | 2019-11-01 | 2019-09-06 |
| Rituximab for HTLV-1-associated Myelopathy Rituximab - HTLV-1-associated Myelopathy | Phase 2 | Unknown | First Affiliated Hospital of Fujian Medical University | 100 | 2019-08-15 | 2022-04-19 |
Diphtheria (2) · Haemophilus Infections (2) · Hepatitis B (2) · Poliomyelitis (2) · Tetanus (2) · Whooping Cough (2) · Paraparesis, Tropical Spastic (1)
Central Nervous System Diseases (3) · Central Nervous System Infections (3) · Infections (3) · Nervous System Diseases (3) · Neuroinflammatory Diseases (3) · RNA Virus Infections (3) · Spinal Cord Diseases (3) · Virus Diseases (3) · Actinomycetales Infections (2) · Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Blood-Borne Infections (2) · Bordetella Infections (2) · Clostridium Infections (2)
Rituximab (1) · Vaccines, Combined (1)
LG Chem (2) · First Affiliated Hospital of Fujian Medical University (1)
China (1)